Financial Times | Axovant prepares to start pair of dementia drugs trials Financial Times LBD is an umbrella term for forms of dementia that are caused by the build-up of proteins known as Lewy bodies in the brain, such as Parkinson's disease. It is the second most common form of dementia after Alzheimer's, but has attracted little ... Axovant Announces Expansion of Dementia Drug Development Pipeline and Reports ... |